Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Dryness Symptoms in Primary Sjögren's Syndrome
NCT04793646Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Apr 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: EULAR Sjogren's Syndrome Patient Reported Index at 3 months. Started Apr 2021; status: completed.
02
Drugs
acetylcysteine
Beyond the preview
Go deeper on NCT04793646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04793646.